New insights into biomarkers and probes for prostate cancer

Researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang, along with international collaborators, detail significant advances in the identification and application of biomarkers for prostate cancer (PCa). Credit: Keyi Li, Department of Endoscope, General Hospital of Northern Theater Command In a recent comprehensive review published in Cyborg Bionic Systems, researchers detail significant advances in the identification and application of biomarkers for prostate cancer (PCa). This critical insight is pivotal as prostate cancer remains one of the most common malignancies among men globally, emphasizing the urgent need for effective diagnostic and therapeutic strategies. The team Read More